Stanford Medicine has decided to pause gender-affirming surgeries for individuals under 19 years old, responding to increasing federal scrutiny concerning trans health care. While surgeries are on hold, the institution will continue offering services such as hormone therapy and behavioral health support. This decision is influenced by a recent executive order from President Trump that restricts funding for pediatric gender transition interventions. Despite support from key medical associations asserting that such care is critical for transgender youth, the legal and political climate remains contentious, notably following a Supreme Court ruling concerning hormone therapy bans.
Stanford Medicine has paused gender-related surgical procedures for patients under 19, citing evolving federal guidance. This decision comes amid heightened scrutiny of trans health care for youth.
Federal pressure on gender-affirming care has mounted since President Trump signed an executive order asserting that medical professionals are maiming and sterilizing children through irreversible medical interventions.
Collection
[
|
...
]